Hybrid imaging devices, such as SPECT/CT, are finding widespread acceptance within the clinical environment.
Nuclear medicine imaging continues to evolve as the industry rides the innovation wave ensuring high image quality, increased diagnostic confidence, improved treatment planning, and faster workflows.
2016 saw the mid-segment take a beating, with preference for 16- and 128-slice equipment.
The sector reeling under the recent increase in customs duty will require government intervention to get back on track.
Combining PET or SPECT with CT allows the lesions to be identified easily by virtue of its high sensitivity and contrast which is leading to an increase in installations of hybrid systems and a corresponding decline in standalone PET and SPECT systems worldwide.
While PET-CT and SPECT-CT scanners are the most important molecular imaging techniques in nuclear medicine, this is not being reflected in actual procurement.
Developments in hybrid imaging are increasing the utility of nuclear medicine while improving patient safety and cost efficiency significantly through reduced need for repeat examinations.